Short answer
SHOULDER INNOVATIONS, INC. (SI) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $16M (up 37.7% year over year) with net income of −$7M.
Q3 2026 key financials · XBRL
- Revenue
- $16M
- +37.7% YoY · −5.7% QoQ
- Net income
- −$7M
- +19.3% YoY · +30.6% QoQ
- Operating margin
- -46.9%
- Gross margin
- 78.5%
- EPS (diluted)
- −$0.33
- −100.1% YoY · +32.7% QoQ
Source: XBRL data from the SHOULDER INNOVATIONS, INC. (SI) Q3 2026 10-Q on SEC EDGAR. USD.
SHOULDER INNOVATIONS, INC. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $16.191M, up 37.7% YoY from $11.756M, driven by higher implant-system sales and customers
- Gross margin 78.5% vs 76.2% YoY, net loss $7.048M vs $8.729M
- Implant systems sold 1,976 vs 1,503 YoY, the strongest reported operating metric
- Nine-month operating cash outflow $26.142M, cash and marketable securities $92.334M at September 30
- Outlook: funding expected for at least 12 months, with continued losses and increased commercial and R&D spending ahead
Risk Factors
- No material changes identified from the 2025 Annual Report’s risk factors
- Equity investment risk: common-stock investors could lose all or part of their investment
- Business uncertainty risk: unknown or currently immaterial risks could materially harm operations
- Market risk: adverse developments could reduce the common-stock market price
- Disclosure risk: investors must assess incorporated annual-report risks alongside quarterly information
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SHOULDER INNOVATIONS, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.